BSE: IPCALAB - Ipca Laboratories Limited

Lønnsomhet i seks måneder: -11.06%
Utbytte: +0.27%

Kampanjeplan Ipca Laboratories Limited


Om selskapet Ipca Laboratories Limited

Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic.

flere detaljer
The company also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, hematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. It also exports its products worldwide. The company was incorporated in 1949 and is based in Mumbai, India.

ISIN INE571A01038
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.3888
Дивиденд ао 4
Сайт https://www.ipca.com
Цена ао 1298.5
Prisendring per dag: -0.0578% (1298.5)
Prisendring per uke: -2.47% (1330.6)
Prisendring per måned: -8.63% (1420.4)
Prisendring over 3 måneder: -15.43% (1534.55)
Prisendring over seks måneder: -11.06% (1459.05)
Prisendring per år: +9.7% (1183.05)
Prisendring over 3 år: +29.65% (1000.95)
Prisendring over 5 år: +3.54% (1253.35)
Prisendring over 10 år: 0% (1297.75)
Prisendring siden begynnelsen av året: -17.98% (1582.25)

Undervurdering

Navn Betydning Karakter
P/S 3.99 4
P/BV 3.93 4
P/E 55.5 2
EV/EBITDA 19.72 6
Total: 5.25

Effektivitet

Navn Betydning Karakter
ROA, % 5.55 2
ROE, % 8.99 3
Total: 2.83

Utbytte

Navn Betydning Karakter
Div yield, % 0.271 0.68
DSI 0.8571 8.57
Total: 3.18

Plikt

Navn Betydning Karakter
Debt/EBITDA 1.32 8
Total: 8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 63.93 8
Lønnsomhet Ebitda, % 40.85 6
Lønnsomhet EPS, % -10.08 0
Total: 4.8

Veileder Stillingstittel Betaling Fødselsår
Mr. Premchand Godha A.C. A., B. Com., CA Executive Chairman 112.65M 1946 (79 år)
Mr. Ajit Kumar Bhanwarlal Jain A.C.A., B.Sc. CFO, MD & Executive Director 77.54M 1955 (70 år)
Mr. Prashant Premchand Godha Executive Director 46M 1975 (50 år)
Mr. Pawan Kothari Vice President of Operations N/A 1965 (60 år)
Mr. Vishnu Saran Singh Kushwaha Vice President of Technical N/A 1968 (57 år)
Mr. Sunil Ghai President of Marketing N/A 1963 (62 år)
Mr. Sameer S. Tamhane Senior Vice President of Human Resources N/A 1967 (58 år)
Dr. Ashok Kumar President of R&D - Chemicals N/A 1954 (71 år)
Mr. Pranay Premchand Godha CEO, MD & Executive Director 50.98M 1972 (53 år)
Mr. Harish Pandurang Kamath Compliance Officer, Corporate Counsel & Company Secretary 1959 (66 år)

Adresse: India, Mumbai, 125 Kandivli Industrial Estate - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.ipca.com